Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 14, 2016; 22(38): 8540-8548
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8540
Published online Oct 14, 2016. doi: 10.3748/wjg.v22.i38.8540
Table 1 Basal characteristic in patients with bipolar disorder and control subjects representative of a general population
Bipolar disorder | Controls | P value | |
(n = 136) | (n = 136) | ||
Mean age (SD) (yr) | 49.9 (14.1) | 51.0 (11.4) | 0.505 |
Women | 61% (n = 83) | 60% (n = 81) | 0.804 |
Mean body mass index (SD) (kg/m2) | 27.0 (5.50) | 25.41 (3.19) | 0.0051 |
Median HADS scores (IQR): | |||
HADS-anxiety | 5 (7) | 4 (5) | 0.0011 |
HADS-depression | 3 (5) | 3 (3) | 0.0221 |
PSQ index (IQR) | 0.27 (0.27) | NA | |
Median GSRS scores (IQR): | |||
Abdominal pain | 1.00 (2.00) | 0.50 (1.50) | 0.076 |
Bloating | 1.00 (1.67) | 0.50 (1.34) | 0.419 |
Diarrhoea | 0.50 (1.50) | 0.25 (0.75) | 0.0021 |
Constipation | 0 (2.00) | 0 (1.00) | 0.310 |
Satiety | 0 (1.00) | 0 (0.50) | 0.0191 |
Dyspepsia | 0 (1.00) | 0.33 (0.67) | 0.850 |
Reflux | 0 (1.00) | 0 (0.50) | 0.376 |
Total GSRS-IBS | 9.00 (17.00) | 7.00 (13.00) | 0.0201 |
Consulters for: | |||
Any functional GI disorder | 25% (n = 34) | 17% (n = 23) | 0.108 |
IBS | 12% (n = 17) | 10% (n = 14) | 0.582 |
Table 2 Control subjects and patients with bipolar disorder with low scores on depression and low scores on anxiety score vs patients with high scores on depression and/or high scores on anxiety
Bipolar patients with HADS-D ≥ 8 and/or HADS-A ≥ 9 (n = 48) | Bipolar patients with HADS-D < 8 and HADS-A < 9 (n = 88) | Controls with HADS-D < 8 and HADS-A < 9 (n = 118) | |
Mean age (SD) (yr) | 46.7 (12.8) (P = 0.048)1 | 51.7 (14.4) | 51.5 (11.8) (P = 0.903) |
Proportions of women | 58% (n = 28) (P = 0.634) | 62% (n = 55) | 59% (n = 70) (P = 0.644) |
Mean Body mass index (kg/m2) (SD) | 27.2 (4.6) (P = 0.632) | 26.8 (5.97) | 25.6 (3.26) (P = 0.063) |
Median HADS score (IQR) | |||
HADS-anxiety | 10.5 (5.0) | 3.0 (4.0) | 3.0 (4.0) (P = 0.660) |
HADS-depression | 9.0 (9.0) | 2.0 (3.0) | 2.0 (3.0) (P = 0.505) |
PSQ index (IQR) | 0.47 (0.28) (P < 0.001)1 | 0.20 (0.17) | NA |
Median GSRS score (IQR): | |||
Abdominal pain | 1.50 (2.50) (P = 0.002)1 | 0.50 (1.50) | 0 (1.50) (P = 0.558) |
Bloating | 1.67 (2.33) (P < 0.001)1 | 0.67 (1.33) | 0.67 (1.67) (P = 0.415) |
Diarrhoea | 1.25 (2.25) (P < 0.001)1 | 0.50 (1.00) | 0.25 (0.75) (P = 0.107) |
Constipation | 0 (2.00) (P = 0.380) | 0 (1.50) | 0 (1.00) (P = 0.453) |
Satiety | 0.50 (2.00) (P = 0.003)1 | 0 (0.50) | 0 (0.50) (P = 0.513) |
Dyspepsia | 0.67 (1.33) (P = 0.002)1 | 0 (0.67) | 0.33 (0.67) (P = 0.291) |
Reflux | 0 (2.13) (P = 0.098) | 0 (0.88) | 0 (0.50) (P = 0.796) |
Total GSRS-IBS | 15.0 (23.0) (P < 0.001)1 | 7.00 (12.0) | 6.50 (13.0) (P = 0.513) |
Consulters: | |||
For any functional GI disorder | 29% (n = 14) (P = 0.407) | 23% (n = 20) | 14% (n = 17) (P = 0.131) |
IBS | 17% (n = 8) (P = 0.290) | 10% (n = 9) | 10% (n = 12) (P = 0.995) |
Median number of drugs (IQR) | 3.0 (3.0) (P = 0.557) | 3.0 (3.0) | 1.0 (2.0) (P < 0.001)1 |
Table 3 Hospital Anxiety Depression Scale scores and Perceived Stress Questionnaire index in correlation to different gastrointestinal symptom scores in patients with bipolar disorder (n = 136)
HADS-Anxiety score. | HADS-Depression score. | PSQ index. | |
rs (P value) | rs (P value) | rs (P value) | |
Abdominal pain | 0.295 (0.001)1 | 0.248 (0.004)1 | 0.261 (0.002)1 |
Bloating | 0.304 (< 0.001)1 | 0.365 (< 0.001)1 | 0.376 (< 0.001)1 |
Diarrhoea | 0.334 (< 0.001)1 | 0.225 (0.009)1 | 0.268 (0.002)1 |
Constipation | 0.099 (0.254) | 0.028 (0.751) | 0.063 (0.473) |
Satiety | 0.222 (0.010)1 | 0.253 (0.003)1 | 0.333 (< 0.001)1 |
Dyspepsia | 0.293 (0.001)1 | 0.205 (0.017)1 | 0.287 (0.001)1 |
Reflux | 0.245 (0.004)1 | 0.122 (0.160) | 0.235 (0.007)1 |
Total GSRS-IBS score | 0.336 (< 0.001)1 | 0.328 (< 0.001)1 | 0.348 (< 0.001)1 |
Table 4 Comparison between patients with bipolar disorder who report high respective low scores on the Gastrointestinal Symptom Rating Scale for Irritable Bowel Syndrome
HIGH GSRS-IBS SCORE | LOW GSRS-IBS SCORE | P value | |
(> 9) | ( ≤ 9) | ||
(n = 65) | (n = 71) | ||
Mean age (SD)(yr) | 49.7 (13.7) | 50.1 (14.5) | 0.571 |
Women | 71% (n = 46) | 52% (n = 37) | 0.0261 |
BMI (SD) | 27.2 (4.46) | 26.7 (6.32) | 0.45 |
Median HADS scores (IQR) | |||
Anxiety score (median) | 6.0 (9.0) | 4.0 (6.0) | 0.0011 |
Depression score (median) | 4.0 (8.0) | 2.0 (4.0) | 0.0021 |
PSQ index (IQR) | 0.32 (0.26) | 0.21 (0.23) | < 0.0011 |
Consulters for: | |||
Any functional GI disorder | 29% (n = 19) | 21% (n = 15) | 0.276 |
IBS | 18% (n = 12) | 7% (n = 5) | 0.067 |
Bipolar type I | 46% (n = 40) | 54% (n = 48) | 0.460 |
Bipolar type II | 52% (n = 25) | 37% (n = 23) | |
Medications: | |||
Lithium | 51% (n = 33) | 42% (n = 31) | 0.320 |
Neuroleptics | 28% (n = 18) | 20% (n = 14) | 0.273 |
Anti-epileptics | 31% (n = 20) | 34% (n = 24) | 0.706 |
SSRI | 14% (n = 9) | 11% (n = 8) | 0.796 |
SNRI | 9% (n = 6) | 6% (n = 4) | 0.519 |
Benzodiazepines | 17% (n = 11) | 6% (n = 4) | 0.053 |
Drugs for insomnia | 26% (n = 17) | 10% (n = 7) | 0.0141 |
Drugs for IBS | 11% (n = 7) | 1% (n = 1) | 0.0281 |
Antacids | 15% (n = 10) | 7% (n = 5) | 0.171 |
Statines | 12% (n = 8) | 8% (n = 6) | 0.575 |
Levothyroxine | 26% (n = 17) | 13% (n = 9) | 0.052 |
≥ 3 drugs | 64% (n = 41) | 54% (n = 38) | 0.214 |
Table 5 Logistic regression analysis studying factors which may influence gastrointestinal symptoms in patients with bipolar disorder
Patients with bipolar disorder and GSRS-IBS > 9 vs patients with bipolar disorder and GSRS-IBS ≤ 9 | ||
Unadjusted OR | Adjusted OR | |
Age | 1.00 (0.97-1.03) | 1.01 (0.97-1.04) |
Sex | 2.23 (1.09-4.52)1 | 2.37 (1.07-5.24)1 |
(male reference) | ||
Body mass index | 1.02 (0.95-1.09) | 1.01 (0.93-1.08) |
HADS-Depression ≥ 8 | 5.54 (2.07-14.8)1 | 3.64 (1.07-12.4)1 |
(< 8 reference) | ||
HADS-Anxiety ≥ 9 | 2.89 (1.34-6.22)1 | 1.82 (0.64-5.22) |
(< 9 reference) | ||
PSQ index ( ≤ 0.34 reference) | 2.53 (1.21-5.30)1 | 1.30 (0.42-3.99) |
Number of Drugs ≥ 3 | 1.55 (0.77-3.09) | 1.29 (0.59-2.80) |
(< 3 reference) |
- Citation: Karling P, Maripuu M, Wikgren M, Adolfsson R, Norrback KF. Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder. World J Gastroenterol 2016; 22(38): 8540-8548
- URL: https://www.wjgnet.com/1007-9327/full/v22/i38/8540.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i38.8540